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Abstract
Influenza A virus (IAV) recognizes two types of N-acetylneuraminic acid (Neu5Ac) by galactose (Gal) linkages,
Neu5Acα2,3Gal and Neu5Acα2,6Gal. Avian IAV preferentially binds to Neu5Acα2,3Gal linkage, while human IAV
preferentially binds to Neu5Acα2,6Gal linkage, as a virus receptor. Shift in receptor binding specificity of avian IAV
from Neu5Acα2,3Gal linkage to Neu5Acα2,6Gal linkage is generally believed to be a critical factor for its
transmission ability among humans. Surveillance of this shift of highly pathogenic H5N1 avian IAV (HPAI) is thought
to be a very important for prediction and prevention of a catastrophic pandemic of HPAI among humans. In this
study, we demonstrated that receptor binding specificity of IAV bound to sialo-glycoconjugates was sensitively
detected by quantifying the HA gene with real-time reverse-transcription-PCR. The new assay enabled direct
detection of receptor binding specificity of HPAIs in chicken clinical samples including trachea and cloaca swabs in
only less than 4 h.
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Introduction
Influenza A virus (IAV) initiates infection through one of sialic
acids, N-acetylneuraminic acid (Neu5Ac), bonded to terminal
galactose (Gal) of glycoconjugates on the host cell surface. A
membrane glycoprotein of IAV, hemagglutinin (HA), recognizes
two types of linkages between Neu5Ac and Gal,
Neu5Acα2,3Gal and Neu5Acα2,6Gal. IAV has a wide spectrum
of hosts including humans, birds, pigs and horses. Human IAV
shows preferential binding to Neu5Acα2,6Gal, which is
abundantly expressed in respiratory tracts of humans. On the
other hand, avian IAV shows preferential binding to
Neu5Acα2,3Gal, which is abundantly expressed in respiratory
and intestinal tracts of birds [1-3]. These receptor binding
specificities of IAV by sialic acid linkage are thought to be an
important determinant in host specificity. Furthermore, shift in
receptor binding specificity of avian IAV from Neu5Acα2,3Gal
to Neu5Acα2,6Gal has been reported to be one of major
factors for acquisition of avian IAV transmission ability among
humans [4,5]. Infection with the highly pathogenic H5N1 avian
IAV (HPAI) has a high fatality rate (approximately 60% as of
2012) even in cases of human infection [6]. Shift in receptor
binding specificity of HPAI is thought to increase transmission
potential among humans, which may lead to a catastrophic
pandemic. Surveillance of the shift in receptor binding
specificity of HPAI is thought to be very important for prediction
and prevention of an HPAI pandemic among humans.
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Receptor binding specificity of influenza viruses is mainly
determined by a hemagglutination assay with resialylated
erythrocytes [7,8], a solid-phase virus binding assay with sialo-
glycoconjugates [9-11], a thin layer chromatography (TLC)
virus overlay assay with sialo-glycoconjugates [11-14], and by
glycoarray analysis with synthetic and natural glycans [15-17].
Bound viruses to sialo-glycoconjugates are detected by using
specific anti-influenza virus antibodies and an enzyme-labeled
secondary antibody [10,12,15,16] or labeling with fluorescent
dyes such as Alexa 488 [17]. Additionally, high titer of
concentrated IAV, which is propagated in embryonated eggs or
cultured cells from seed virus, is required to determine receptor
binding specificity in these assays. This process takes several
days or more than one week. If there is no appropriate antibody
against the IAV strain of interest, we must prepare a specific
antibody. Our previous studies have shown that glycopolymers
bind strongly with IAV, possibly because of the cluster effect of
sialo-glycoconjugates. Glycopolymers are ϒ-polyglutamic acid
polymers containing N-acetyllactosamine (LacNAc)
glycoconjugates possessing Neu5Acα2,3Gal or
Neu5Acα2,6Gal [18,19]. However, even when glycopolymers
are utilized, a high titer of IAV is required for determination of
the receptor binding specificity of IAV. Since the traditional
assay requires a long time to complete detection for receptor
binding specificity of IAV, it is not easily applied for screening of
the shift in receptor binding specificities of many HPAI stains.
In this study, we tried to directly detect receptor binding
specificity of avian IAV in clinical samples by improving the
detection sensitivity of IAV bound to glycopolymers. Direct
detection from clinical samples should not require a virus
replication process, leading to much reduction of the time to
complete detection of receptor binding specificity. To improve
detection intensity of IAV bound to glycopolymers immobilized
on a microplate, we quantified the HA gene of IAV using real-
time PCR and one-step reverse-transcription (RT)-PCR. The
new assay enabled detection of receptor biding specificities of
IAVs with a minimum 50% egg infectious dose (EID50) of 104.02.
The new assay also enabled direct detection of receptor
binding specificity of HPAIs in clinical samples such as trachea
swab and cloaca swab samples, without influence of the swab
itself. Although the traditional assay usually required more than
one week, the new assay finished the detection in only less
than 4 h directly from clinical samples.
Materials and Methods
Viruses, glycopolymers, and swab samples
IAVs A/Memphis/1/1971 (H3N2) (M71) and A/duck/Hong
Kong/313/4/1978 (H5N3) (D313) were propagated in 10-day-
old embryonated hen’s eggs for 2 days at 34 °C and were
concentrated by centrifugation.
ϒ-Polyglutamic acid polymers containing 5-aminopentyl β-
LacNAc (PGA), 5-aminopentyl β-Neu5Acα2,3LacNAc
(α2,3PGA), or 5-aminopentyl β-Neu5Acα2,6LacNAc (α2,6PGA)
were synthesized as described previously [18]. The degree of
polymerization (DP) of glutamic acid residues is 6557.
Molecular weights of PGA, α2,3PGA, and α2,6PGA were
2,200,000, 3,000,000 and 3,000,000, respectively. The degree
of substitution of sialo-sugar derivatives based on DP of non-
sugar ϒ-PGA is 43% in both α2,3PGA and α2,6PGA (Figure
S1).
Swabs were obtained from five white leghorn chickens
(brand, Julia) bred in Shizuoka Prefectural Livestock Institute,
Swine and Poultry Research Center. Each poultry trachea
swab sample was a cotton-tipped swab suspended in 0.5 ml
phosphate-buffered saline (PBS; pH 7.2, 131 mM NaCl, 14 mM
Na2HPO4, 1.5 mM KH2PO4, and 2.7 mM KCl). Each poultry
cloaca swab sample was a cotton-tipped swab suspended in
1.5 ml phosphate-buffered saline. Trachea swabs and cloaca
swabs from HPAI-infected chickens were given from swab
samples reported previously [20]. HPAI strains, A/chicken/
Shimane/1/2010 (H5N1) (CS10) and A/chicken/Miyazaki/
S4/2011 (H5N1) (CM11), were used. Accession numbers in
GenBank are AB684240 for CS10 HA and AB684242 for CM11
HA. Both HA genes are included in clade 2. 3. 2. 1. of HPAI
H5HA genes. HA sequences of the two viruses are closely
related (only two differences at the amino acid level). The EID50
per 200 μl in the trachea swab and the cloaca swab containing
CS10 were 106.53 and 104.38, respectively. The EID50 per 200 μl
in the trachea swab and the cloaca swab containing CM11
were 105.46 and 104.32, respectively. We used these four HPAI-
positive samples. All animal experiments were carried out in
biosafety level 3 facilities at the National Institute of Animal
Health, Japan and were approved by the Ethics Committee of
the institute.
Hemagglutination assay
Fifty microliters per well of 2-fold serially diluted virus
suspensions were mixed with 50 μl of 0.5% (v/v) guinea pig red
blood cells on a 96-well U-bottom microplate. After incubation
at 4 °C for 2 h, hemagglutination unit (HAU) was measured.
Detection of Neu5Acα2,3Gal or Neu5Acα2,6Gal
glycoconjugates on PGA by lectins
Fifty nanograms per well of α2,3PGA, α2,6PGA or PGA was
incubated on a Corning 96-well clear flat-bottom polystyrene
Universal-BIND microplate (Corning Life Sciences, Lowell, MA,
USA) at 4 °C for 2 h and immobilized by irradiation of UV at
256 nm for 1 min. After washing with PBS 5 times, the wells
were blocked by incubation of 300 μl/well of 1% lipid-free
bovine serum albumin (BSA) in PBS at 4 °C overnight. After
washing with PBS 5 times, the wells were incubated with 100
μl/well (5 μg/ml) of biotinylated Maackia amurensis lectin
(MAM; J-OIL MILLS, Tokyo, Japan) or biotinylated Sambucus
sieboldiana lectin (SNA; J-OIL MILLS, Tokyo, Japan) at room
temperature for 2 h. After washing with PBS 5 times, the wells
were incubated with 130 μl/well of horseradish peroxidase
(HRP)-labeled streptavidin (SIGMA-ALDRICH, St. Louis, MO,
USA). Finally, the wells were colored as described previously
[11,18].
Measurement of receptor binding specificity of IAVs by
real-time one-step RT-PCR
Two hundred nanograms per well of α2,3PGA or α2,6PGA
was incubated on a Corning 96-well clear flat-bottom
Polystyrene Universal-BIND microplate at 4°C for 2 h and
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immobilized by irradiation of UV at 256 nm for 1 min. After
washing with PBS 5 times, the wells were blocked by
incubation of 300 μl/well of 1% lipid-free BSA in PBS at 4 °C
overnight. After washing with PBS containing 0.01% Tween20
10 times, 50 μl/well of D313 or M71 (2° HAU) in PBS
containing 0.1% lipid-free BSA was incubated 4 °C for 2 h. A
QIAGEN RNeasy Mini kit (QIAGEN, Venlo, Netherlands) was
used to extract viral RNA of IAVs bound to α2,3PGA or
α2,6PGA. After washing with PBS 10 times, the wells were
mixed with 200 μl/well of RLT buffer of the QIAGEN RNeasy
Mini kit. Then 150 μl of RLT buffer and 100 μl of sterilized
distilled water were added to the buffer. After mixing vigorously,
250 μl of 99.5% ethanol was added. The mixture was poured
into the cartridge of the QIAGEN RNeasy Mini kit. After
centrifugation at 8,000 ×g for 1 min, 700 μl of RW1 buffer was
poured into the cartridge. After centrifugation at 8,000 ×g for 1
min, 500 μl of RPE buffer was poured into the cartridge. After
centrifugation at 8,000 ×g for 1 min, 500 μl of RPE buffer was
poured into the cartridge again. Viral RNA in the cartridge was
eluted with 30 μl of RNase-free water. The RNA was stored at
-80 °C until use. Viral HA cDNA copies were measured by
using real-time PCR equipment (Light Cycler ver.2.0; Roche,
Hague Road, IN, USA), a One Step SYBR PrimeScript RT-
PCR PLUS RT-PCR kit (Perfect Real Time) (TaKaRa Bio,
Shiga, Japan), and primer pairs, 5’-
ATGGCAGGGAATGGTAGA-3’ and 5’-
TTGCCTTTTGAGTGGATTC-3’ for the D313 HA gene and 5’-
CCTCATCGAATCCTTGATG-3’ and 5’-
GGGTAACAGTTGCTGAAAGC-3’ for the M71 HA gene.
Primer pairs for the D313 HA gene amplify 95 base pairs
between 1093 and 1187 at D313 HA nucleotide positions,
which are located at the 5’ region side of the HA2 gene. These
primers were designed on the basis of conserved nucleotide
sequences among the D313 HA gene (accession number
AB542809) in 1978, duck H5N3 HA gene (EF597247) in 1976,
and HPAI H5N1 HA genes from various hosts including
chickens (DQ076201, DQ083551, and DQ083565), white
peafowls (DQ083573), mynas (DQ083585), pigeons
(DQ083583), crows (DQ083563), ducks (DQ083581), geese
(AY651332), tigers (AY646167, AY842935, AY972540,
AY972541, AY866475, and AY972539), leopards (AY646175),
and humans (AY627885, AY626143, AY577314, and
AY555153) in 1976 and 2004. Primer pairs for the M71 HA
gene amplify 134 base pairs between 240 and 373 at M71 HA
nucleotide positions, which are located at the 5’ region side of
the HA1 gene. These primers are also used as sequencing
primers for the human IAV H3N2 HA gene. Two microliters of
the viral RNA samples was added to the RT-PCR solution (20
μl/capillary) as a RT-PCR template. For RT reaction, the
solution in the capillary was incubated at 42 °C for 5 min (20
°C/sec) and heated at 95 °C for 10 sec (20 °C/sec). For PCR
reaction (60 cycles), after denaturing at 95 °C for 5 sec (20 °C/
sec), the solution in the capillary was heated at 95 °C for 5 sec
(20 °C/sec), annealed at 55 °C for 15 sec (20 °C/sec), and
extended at 66 °C for 15 sec (20 °C/sec). Standard curve of HA
cDNA copies (cycle values v.s. HA cDNA copies) was made by
use of the expression vector pCAGGS containing the D313 HA
gene between the Sma I site and Xho I site or the M71 HA
gene between the Kpn I site and Sma I site [21] as a template
of real-time PCR.
To investigate influence of contents in poultry swabs on this
receptor binding specificity assay, 25 μl/well of D313 or M71
(2° HAU) in PBS containing 0.1% lipid-free BSA was mixed
with 25 μl/well of a 5-dilution suspension of the supernatant of
the trachea swab or cloaca swab after spin-down for 5 min.
Fifty microliters per well of the mixture was incubated on a
microplate that wells were immobilized with 200 ng/well of
α2,3PGA or α2,6PGA and then blocked with 1% lipid-free BSA
(300 μl/well). For the receptor binding specificity assay of
HPAIs in poultry swabs, supernatants of trachea swabs or
cloaca swabs after spin-down for 5 min were two-times
suspended in PBS. On a microplate that was immobilized with
200 ng/well of α2,3PGA or α2,6PGA and then blocked with 1%
lipid-free BSA (300 μl/well), the wells were incubated with 50
μl/well of the swab supernatants at room temperature for 2 h.
The experiment using HPAIs was performed in a biosafety
level 3 facility until addition of RLT buffer to the wells. The viral
RNA of viruses bound to α2,3PGA or α2,6PGA were extracted
as described above. The amount of HPAI HA genes was
measured by real-time one-step RT-PCR using the primer pair
5’-ATGGCAGGGAATGGTAGA-3’ and 5’-
TCTATTGCCTTTTGAGTAGATTC-3’. The sequence of the
former primer is the same as that of the forward primer for the
D313 HA gene. The latter primer was designed on
approximately the nucleotide location of the reverse primer for
the D313 HA gene (addition of 4 nucleotides and replacement
of 1 nucleotide), because a base “C” at nucleotide position
1174 in D313 HA (D313 HA numbering) was substituted to a
base “T” in both HPAI HAs. Primer pairs for the HPAI HA gene
amplify 108 base pairs (plus 9 nucleotides in the trypsin-
sensitive cleavage site) between nucleotide positions 1093 and
1191 (D313 HA numbering). The entire gene of HPAI HA cDNA
was amplified by PCR (20 sec at 94 °C for denaturing, 30 sec
at 58 °C for annealing, and 7 min at 72 °C for extension) using
DyNAzyme EXT DNA polymerase (Thermo Fisher Scientific
K.K., Yokohama, Japan) and primer pair 5’-
TATTCGTCTCAGGGAGCAAAAGCAGGGG-3’ and 5’-
ATATCGTCTCGTATTAGTAGAAACAAGGGTGTTTT-3’. The
amplified HA genes were purified from band cut at
approximately 1.8 k base pairs on 1% agarose gel, and the
amount of HA genes was quantified by using Nanodrop 1000
(Thermo Fisher Scientific K.K., Yokohama, Japan). Standard
curve of HPAI HA cDNA copies (cycle values v.s. HA cDNA
copies) was made by use of the amplified HA genes as a
template of real-time PCR.
Solid-phase virus binding assay by using anti-IAV
antibody
A microplate with α2,3PGA (200 ng/well) was blocked with
1% lipid-free BSA in PBS at 4 °C overnight and was then
incubated with different titers of avian IAV D313 (two serial
dilutions from 24 to 2-3 HAU/50 μl) for 2 h at 4 °C. Viruses
bound to α2,3PGA were detected by rabbit anti-D313
polyclonal antibody and HRP-labeled goat anti-rabbit IgG
antibody. Finally, amounts of viruses bound to α2,3PGA were
Direct Virus Receptor Binding Assay from Samples
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measured by development of O-phenylenediamine (OPD), as
previously reported [11,18].
Results
Binding specificity of Neu5Acα2,3Gal and
Neu5Acα2,6Gal on a PGAs-immobilized microplate by
lectins
α2,3PGA (possessing Neu5Acα2,3LacNAc), α2,6PGA
(possessing Neu5Acα2,6LacNAc), and PGA (possessing
LacNAc) were covalently immobilized on a microplate by
irradiation of UV (Figure S1). We checked whether lectins
could recognize terminal sialic acid linkages of glycoconjugates
on the immobilized PGAs, Neu5Acα2,3Gal and
Neu5Acα2,6Gal. After blocking of lipid-free BSA, the wells were
incubated with biotinylated SNA or biotinylated MAM. Lectins
that bound to glycoconjugates of PGAs were detected with
HRP-labeled streptavidin. SNA, which could recognize
Neu5Acα2,6Gal, bound to α2,6PGA only (Figure 1A). On the
other hand, MAM, which could recognize Neu5Acα2,3Gal,
bound to α2,3PGA only (Figure 1B). This result indicates that
glycoconjugates of the immobilized PGAs maintain sialic acid
linkages that lectins can recognize and that the immobilized
PGAs are useful for detection of IAV receptor binding
specificity.
Highly sensitive detection of receptor binding
specificity of IAVs by using real-time PCR
To improve detection sensitivity of receptor binding
specificity of IAVs, we tried to measure genes of virus bound to
glycoconjugates possessing Neu5Acα2,3Gal and
Neu5Acα2,6Gal by using real-time PCR. Wells with
immobilized α2,3PGA were blocked with lipid-free BSA and
incubated with 22, 2°, 2-4, or 2-8 HAU/50 μl of avian IAV strain
D313, which preferentially recognized Neu5Acα2,3Gal in a
solid-phase virus binding assay [18]. Materials other than the
viruses that had bound to α2,3PGA were washed out 5 times
before extraction of viral RNA. HA cDNA copies of D313 bound
to α2,3PGA were measured by one-step RT-PCR. Correlation
factors between HAU and HA cDNA copies were 0.997 and
0.982 within the ranges of 22 to 2-4 HAU and 22 to 2-8 HAU,
respectively. We estimated that receptor binding of D313 to
α2,3PGA was able to be linearly measured within the range of
22 to 2-4 HAU from a correlation factor of more than 0.99
(Figure 2A). Here, we tried highly sensitive detection of
receptor binding specificity of IAVs at 2° HAU. Usually, when a
solid-phase virus binding assay and a TLC virus binding assay
are performed using this titer, receptor binding specificities
between Neu5Acα2,3Gal and Neu5Acα2,6Gal cannot be
detected because of the weak signal of virus binding to
glycoconjugates. Wells with immobilized α2,3PGA or α2,6PGA
were blocked with lipid-free BSA and incubated with 2° HAU/50
μl of D313 or human IAV strain M71, which preferentially
recognized Neu5Acα2,6Gal in a solid-phase virus binding
assay [18]. HA cDNA copies of bound D313 and M71 were
measured by using real-time PCR. Melting temperatures of all
PCR products were confirmed to be similar to approximately 81
°C in a positive control (standard curve) of D313 and M71,
indicating that PCR products detected were the same HA gene.
Average HA cDNA copies of D313 were 2.99 ×104 (S.E. ± 3.15
×103) for α2,3PGA and 6.37 ×103 (S.E. ± 1.09 ×103) for
α2,6PGA. HA cDNA copies of M71 were 2.86 ×104 (S.E. ± 9.56
×102) for α2,3PGA and 6.68 ×104 (S.E. ± 2.13 ×104) for
Figure 1.  Lectin binding to PGAs immobilized on a microplate.  α2,3PGA, α2,6PGA, and PGA containing an LacNAc chain
(each 50 ng/well) on a microplate were reacted with biotinylated lectins, SNA (A) and MAM (B). Each value (standard error; S.E.) is
the average from three independent experiments. OD, optical density.
doi: 10.1371/journal.pone.0078125.g001
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α2,6PGA. D313 preferentially bound to α2,3PGA (Figure 3A),
while M71 preferentially bound to α2,6PGA (Figure 3B),
indicating that this assay enables detection of receptor binding
specificity of avian and human IAVs. For detection of receptor
binding specificity of IAV, a traditional solid-phase virus binding
assay using α2,3PGA and α2,6PGA has usually been
performed with 25 to 28 HAU of IAV [18,19,22]. Virus titer in the
new assay described in this paper showed 32- to 256-times
higher sensitivity than the conventional virus titer in a traditional
assay.
We tried a solid-phase virus binding assay with α2,3PGA. A
microplate with α2,3PGA was incubated with two serial
dilutions from 24 to 2-3 HAU/50 μl of D313. D313 bound to
α2,3PGA was detected by rabbit anti-D313 antibody. IAV
binding signal was not detected under the 21 HAU because of
less than 0.1 at absorbance (Figure 2B). The result indicates
that the new assay is sensitive compared to traditional assays,
at least solid-phase virus binding assay.
Direct detection of receptor binding specificity of avian
IAVs from clinical samples
We tried to directly detect receptor binding specificity of
avian IAV in poultry clinical samples including trachea swab
and cloaca swab samples. To check influence of contents in
poultry swabs on detection for receptor binding specificity of
avian and human IAV, D313 and M71 were mixed with poultry
trachea swabs or cloaca swabs obtained from five chickens.
The supernatant after spin-down was used as a virus-swab
suspension. Wells with immobilized α2,3PGA or α2,6PGA were
blocked with lipid-free BSA and incubated with a virus-swab
suspension (2-1 HAU/50 μl) of D313 or M71. HA cDNA copies
of bound D313 and M71 were measured by using real-time
PCR. Melting temperatures of all PCR products were confirmed
to be similar to approximately 81°C in a positive control
(standard curve) of D313 and M71. HA cDNA copies of D313
were 5.66 ×103 (S.E. ± 1.12 ×103) for α2,3PGA and 2.23 ×102
(S.E. ± 2.75 ×101) for α2,6PGA in the presence of a trachea
swab, and they were 2.98 ×103 (S.E. ± 3.56 ×102) for α2,3PGA
and 6.04 ×101 (S.E. ± 6.55 ×101) for α2,6PGA in the presence
Figure 2.  Detection of virus binding to α2,3PGA by real-time PCR and by solid-phase virus binding assay.  A, A microplate
was immobilized with 200 ng/well of α2,3PGA and then blocked with 1% lipid-free BSA in PBS at 4 °C overnight. Different titers of
avian IAV D313 (22, 2°, 2-4, and 2-8 HAU/50 μl) were incubated for 2 h at 4 °C on microplates that were immobilized with α2,3PGA.
Viral RNAs of viruses bound to α2,3PGA were extracted. Amount of HA cDNA copies was measured by using real-time PCR. Each
value (S.E.) is the average from three independent experiments. Receptor binding of D313 to α2,3PGA was able to be linearly
measured within the range of 22 to 2-4 HAU from a correlation factor of more than 0.99. B, A microplate was immobilized with 200
ng/well of α2,3PGA and then blocked with 1% lipid-free BSA in PBS at 4 °C overnight. Different titers of avian IAV D313 (24 to 2-3
HAU/50 μl) were incubated on a microplate. Viruses bound to α2,3PGA were detected by rabbit anti-D313 polyclonal antibody.
doi: 10.1371/journal.pone.0078125.g002
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of a cloaca swab. HA cDNA copies of M71 were 1.73 ×103
(S.E. ± 5.35 ×102) for α2,3PGA and 5.22 ×102 (S.E. ± 4.81
×102) for α2,6PGA in the presence of a trachea swab, and they
were 6.10 ×103 (S.E. ± 9.64 ×102) for α2,3PGA and 1.72 ×104
(S.E. ± 2.06 ×103) for α2,6PGA in the presence of a cloaca
swab. D313 preferentially bound to α2,3PGA in the presence of
a trachea swab (Figure 4A) and a cloaca swab (Figure 4B),
while M71 preferentially bound to α2,6PGA in the presence of a
trachea swab (Figure 4C) and a cloaca swab (Figure 4D).
These results, which are similar to the results of receptor
binding specificity shown in Figure 3 in the absence of poultry
swabs, indicate that poultry trachea and cloaca swabs have no
effect on receptor binding specificity of avian and human IAVs
for this assay. As negative controls, we assayed 10-diluted
suspensions of three trachea and cloaca swabs without viruses
on a microplate immobilized with α2,3PGA and α2,6PGA by
RT-PCR. RT-PCR using all primer pairs tested showed no
nonspecific detection for healthy chicken swabs (data not
shown). Again, we performed additional run of experiments of
D313 and M71 in the presence of a trachea swab or cloaca
swab. These results indicated receptor binding specificities
shown in Figure 4 (Table 1). They support the reliability of
receptor binding specificities detected by the new assay.
We then tried to directly detect receptor binding specificity of
HPAIs in clinical samples from chickens. For clinical samples,
we used trachea swabs and cloaca swabs from chickens
infected with the HPAI strain CM10 or CS11 reported
previously [20]. Wells with immobilized α2,3PGA or α2,6PGA
were blocked with lipid-free BSA and incubated with the
supernatants of swabs after spin-down. HA cDNA copies of
CM10 and CS11 were measured by using real-time PCR.
Melting temperatures of all PCR products were confirmed to be
similar to approximately 82 °C in a positive control (standard
curve) of CM10 and CS11. HA cDNA copies of CM10 were
1.06 ×103 (S.E. ± 7.87 ×101) for α2,3PGA and 1.89 ×102 (S.E. ±
4.93 ×101) for α2,6PGA in trachea swabs, and they were 3.52
×101 (S.E. ± 7.22) for α2,3PGA and 1.05 ×101 (S.E. ± 3.58) for
α2,6PGA in cloaca swabs. HA cDNA copies of CS11 were 1.67
×103 (S.E. ± 1.98 ×102) for α2,3PGA and 5.28 ×102 (S.E. ± 1.23
×102) for α2,6PGA in trachea swabs, and they were 3.79 ×101
(S.E. ± 2.23 ×101) for α2,3PGA and 1.21 ×101 (S.E. ± 4.59) for
α2,6PGA in cloaca swabs. EID50 values in the cloaca swabs
were approximately 101- to 102-times smaller than those in
trachea swabs. This probably resulted in lower HA cDNA
copies in cloaca swabs than in trachea swabs. Both CM10 in a
trachea swab (Figure 5A) and a cloaca swab (Figure 5B) and
CS11 in a trachea swab (Figure 5C) and a cloaca swab (Figure
Figure 3.  Detection of receptor binding specificity of avian and human viruses by real-time PCR.  A microplate was
immobilized with 200 ng/well of α2,3PGA or α2,6PGA and then blocked with 1% lipid-free BSA in PBS at 4 °C overnight. Avian IAV
D313 (A) and human IAV M71 (B) (2° HAU, 50 μl/well) were incubated for 2 h at 4 °C on microplates that were immobilized with
α2,3PGA or α2,6PGA. Viral RNAs of viruses bound to α2,3PGA or α2,6PGA were extracted. Viruses that bound to α2,3PGA or
α2,6PGA were measured as copy number of HA cDNA by using real-time PCR. Each value (S.E.) is the average from three
independent experiments. The general property for receptor binding specificities (preferential binding of avian IAV to
Neu5Acα2,3Gal and of human IAV to Neu5Acα2,6Gal) was detected.
doi: 10.1371/journal.pone.0078125.g003
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5D) showed preferential binding to α2,3PGA compared to
α2,6PGA, similar to the nature of almost all avian IAVs. This
assay had adequate sensitivity for direct detection of receptor
binding specificity of avian IAVs in clinical samples.
The forward primer used in this one-step real-time RT-PCR
against H5HA cDNA is conserved among many H5HA genes
isolated from various hosts, including chickens, white peafowls,
mynas, pigeons, crows, ducks, geese, tigers, leopards, and
Figure 4.  Influence of swabs from chickens on the real-time PCR assay for receptor binding specificity.  A microplate was
immobilized with 200 ng/well of α2,3PGA or α2,6PGA and then blocked with 1% lipid-free BSA in PBS at 4 °C overnight. Avian IAV
D313 (A and B) or human IAV M71 (C and D) (2° HAU, 25 μl/well) was mixed with a 5-dilution suspension of a trachea swab (A and
C) or cloaca swab (B and D) (25 μl/well) from healthy chickens. The mixtures (50 μl/well) were incubated for 2 h at 4 °C on
microplates that were immobilized with α2,3PGA or α2,6PGA. Viral RNAs of viruses bound to α2,3PGA or α2,6PGA were extracted.
Viruses that bound to α2,3PGA or α2,6PGA were measured as copy number of HA cDNA by using real-time PCR. The data (S.E.)
is the average from three independent experiments. The trachea swab and cloaca swab had no influence on this assay.
doi: 10.1371/journal.pone.0078125.g004
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humans, in 1976, 1978, 2004, 2010, and 2011. The reverse
primer against HPAI H5HA is conserved among many HPAI
H5HA cDNAs from avian hosts, including chickens, ducks,
swans, and owls, in 2007 to 2012 (in 100 hits on a search in
NCBI nucleotide blast, http://blast.ncbi.nlm.nih.gov/Blast.cgi).
These primers will be useful for detection of recent HPAI H5HA
genes from wild birds and chickens since 2007.
Discussion
Traditional assays require high titers of influenza viruses, 25
to 210 HAU/50 μl for a solid-phase virus binding assay
[9-11,18,19], 28 to 210 HAU/10 ml for a TLC virus overlay assay
[11-13,23], and 28 to 29 HAU/ml or 10 μg/ml (approximately 28
HAU/50 μl of A/Puerto Rico/8/1934 H1N1 strain) for a glycan
array [15,16]. To obtain a high titer of virus, clinical samples
must first be inoculated to embryonated eggs or cultured cells
such as Madin-Darby canine kidney (MDCK) cells to replicate
and collect virus stock (chorioallantoic fluid of an egg) as seed
virus. Furthermore, seed virus of most virus strains including all
subtypes must usually be propagated in a large amount of
embryonated eggs or cultured cells to obtain a high titer of
concentrated virus required for an adequate number of the
traditional assays. Anti-IAV antibodies are required for
detection of virus bound to sialo-glycoconjugates. However,
since envelope glycoproteins of IAV strains are various in
antigenicity (subtypes: HA 1 to 17, NA 1 to 10), a reactive
antibody against the IAV strain tested must also be prepared. If
a virus in clinical samples shows extremely efficient replication
in eggs or cells, a high titer of seed virus may be able to be
applied to traditional assays. However, seed virus and
adequate amount of concentrated virus are usually required for
traditional assays. In this case, it is estimated that traditional
assays usually take more than one week from collection of a
clinical sample to completion of measurement including the
virus replication process to obtain a high titer of virus, as shown
in Figure S2.
Table 1. Reproduction of receptor binding specificities of
D313 and M71 measured by the new assay in the presence
of swabs.
Assay HA cDNA copies ± S.E. α2,3PGA / α2,6PGA
runs α2,3PGA α2,6PGA ratio
D313 in the presence of trachea swab
1st run 5.66 ×103 ± 1.12 ×103 2.23 ×102 ± 2.75 ×101 25.4
2nd run 2.86 ×104 ± 8.96 ×103 6.35 ×102 ± 2.46 ×102 45.0
D313 in the presence of cloaca swab
1st run 2.98 ×103 ± 0.36 ×102 6.04 ×101 ± 6.56 ×101 49.3
2nd run 1.65 ×104 ± 4.66 ×103 3.83 ×102 ± 7.29 ×101 43.1
M71 in the presence of trachea swab
1st run 1.73 ×103 ± 5.35 ×102 5.22 ×103 ± 4.81 ×102 0.33
2nd run 1.75 ×104 ± 1.85 ×103 3.37 ×104 ± 3.31 ×103 0.52
M71 in the presence of cloaca swab
1st run 6.10 ×103 ± 9.64 ×102 1.72 ×104 ± 2.06 ×103 0.35
2nd run 1.67 ×104 ± 4.83 ×103 3.60 ×104 ± 1.42 ×104 0.46
doi: 10.1371/journal.pone.0078125.t001
The new assay combined with real-time RT-PCR for receptor
binding specificity of IAV was very sensitive and can be
performed in a short time compared to the traditional assays.
The new assay can be performed even with a low titer of IAV.
Furthermore, it can detect receptor binding specificity of avian
IAV directly from clinical samples of chickens, without the need
for seed virus and virus replication to obtain a high titer of the
virus. The virus is bound to sialo-glycoconjugates, a process
that takes 2h. Viral RNA is extracted from virus bound to
glycoconjugates using an RNA extraction kit, a process that
takes less than 1 h, and measured with real-time PCR
equipment using a one-step RT-PCR kit, a process that takes
less than 1 h. The new assay takes a very short time, only less
than 4 h, as shown in Figure S2. Additionally, preparation of
embryonated eggs and maintenance of cultured cells are not
required, unlike in the traditional assays.
When a new subtype emerges (by replacement of a viral
segmented genome between IAVs) or large antigenic
alterations (by amino acid substitutions) of IAV occur,
preparation of a specific antibody takes more than one month
to obtain a large amount of antigen (viral proteins) and to
immunize animals. Since gene sequence analysis requires only
a very small amount of virus, preparation of specific primers
takes only a few days. The new assay can early start,
compared to traditional assays.
When IAV replicates in embryonated eggs, there is a risk of
HA mutation changing receptor binding specificity. A leucine-to-
glutamine substitution at amino acid position 226 in HA (H3 HA
numbering of human H3N2 IAV) has been reported to occur
during virus replication in embryonated eggs and to shift
receptor binding specificity of IAV to Neu5Acα2,3Gal from
Neu5Acα2,6Gal [14]. Virus in clinical samples is thought to be
mixed viruses carrying various mutations. Some particular
viruses show preferential replication by selection of receptor
properties in embryonated eggs or MDCK cells. The
carbohydrate chain on asparagine at amino acid position 131 in
HA (H1 HA numbering of A/USSR/90/77 H1N1 strain)
interferes with binding to Neu5Acα2,6Gal, but it has little or no
effect on binding to Neu5Acα2,3Gal. Lack of a carbohydrate
chain by an asparagine-to-aspartate substitution at the position
results in binding to Neu5Acα2,6Gal. For replication of mixed
viruses with asparagine or aspartate at the site, the virus with
aspartate shows selective replication in MDCK cells expressing
Neu5Acα2,6Gal. On the other hand, the virus with asparagine
shows selective replication in embryonated eggs abundantly
expressing Neu5Acα2,3Gal [24]. Therefore, the virus
replication process for a traditional assay has the risk of HA
mutations and selective virus replication accompanying a
change in receptor binding specificity. In the new assay, there
is no risk of HA mutations, which were caused by the virus
replication process to obtain a high titer of the virus.
In the case of simultaneous infection with more than two
different subtypes of IAVs, receptor binding specificity of each
strain could be detected by using subtype-specific HA primers.
This assay would be beneficial as the primary screening
method for detecting change in receptor binding specificities.
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Figure 5.  Direct detection of receptor binding specificity of HPAIs in swabs by real-time PCR.  A microplate was immobilized
with 200 ng/well of α2,3PGA or α2,6PGA and then blocked with 1% lipid-free BSA in PBS at 4 °C overnight. Trachea swabs (A and
C) and cloaca swabs (B and D) were obtained from chickens infected with HPAIs CS10 (A and B) and CM11 (C and D). Swabs
were suspended in equal amounts of PBS. The swab suspensions (50 μl/well) were incubated for 2 h at 4 °C on microplates that
were immobilized with α2,3PGA or α2,6PGA. Viral RNAs of viruses bound to α2,3PGA or α2,6PGA were extracted. Viruses that
bound to α2,3PGA or α2,6PGA were measured as copy number of HA cDNA by using real-time PCR. Each value (S.E.) is the
average from three independent experiments. Directly from swabs obtained from HPAI-infected chickens, this assay indicated that
HPAIs CS10 and CM11 had the general property of receptor binding specificity of avian IAV (preferential binding to
Neu5Acα2,3Gal).
doi: 10.1371/journal.pone.0078125.g005
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Conclusions
HPAI infection, which has a mortality rate of approximately
60% in humans, shows frequent cases of human infections,
especially in south-eastern Asia. Shift in receptor binding
specificity of avian IAV from Neu5Acα2,3Gal to
Neu5Acα2,6Gal is thought to be one of the major factors for
acquisition of avian IAV transmission ability among humans.
Surveillance of the shift in receptor binding specificity of HPAI
is thought to be very important for prediction and prevention of
a catastrophic pandemic of HPAI among humans. The new
assay enables direct detection of receptor binding specificity of
HPAI in poultry clinical samples. The assay also has some
valuable advantages compared to traditional assays, as
summarized in Table 2. Notably, detection of receptor binding
specificity of HPAI by the new assay can be completed in a
very short time (only less than 4 h), unlike the traditional
assays (more than one week). Our receptor binding assay
combined with real-time RT-PCR would be a beneficial tool for
primary screening in numerous clinical samples to investigate a
shift in receptor binding specificity of HPAI from
Neu5Acα2,3Gal to Neu5Acα2,6Gal.
Supporting Information
Figure S1.  Structure of PGAs. PGAs have an LacNAc chain,
the terminal of which binds with Neu5Ac by α2,3 linkage (A) or
α2,6 linkage (B).
(TIF)
Figure S2.  Comparison of new assay with traditional assay in
a required time.
(TIF)
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Table 2. Valuable advantages of new assay compared to
traditional assay.
Comparison point Traditional assay New assay
HA mutation caused by virus
replication process   
 Risk No risk
Time required More than one week Less than 4 h
Virus detection tool Antibody Primer
Virus replication Required (maintenance ofeggs or cells) Not required
Virus titer high low
doi: 10.1371/journal.pone.0078125.t002
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